Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood–Adulthood Transition
暂无分享,去创建一个
[1] Frederick C. Neidhardt,et al. Escherichia coli and Salmonella :cellular and molecular biology , 2016 .
[2] B. Dallapiccola,et al. Understanding probiotics’ role in allergic children: the clue of gut microbiota profiling , 2015, Current opinion in allergy and clinical immunology.
[3] E. Zoetendal,et al. Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis. , 2015, Gastroenterology.
[4] M. Carabotti,et al. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems , 2015, Annals of gastroenterology.
[5] P. Bytzer,et al. The prevalence of intestinal parasites is not greater among individuals with irritable bowel syndrome: a population-based case-control study. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[6] A. Carroccio,et al. Role of FODMAPs in Patients With Irritable Bowel Syndrome. , 2015, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.
[7] T. Lawley,et al. Pathogens' exploitation of the intestinal food web. , 2014, Cell host & microbe.
[8] Dan Knights,et al. Complex host genetics influence the microbiome in inflammatory bowel disease , 2014, Genome Medicine.
[9] Ivan Merelli,et al. Managing, Analysing, and Integrating Big Data in Medical Bioinformatics: Open Problems and Future Perspectives , 2014, BioMed research international.
[10] K. Lohmann,et al. Next Generation Sequencing and the Future of Genetic Diagnosis , 2014, Neurotherapeutics.
[11] D. Dumitrascu,et al. The relationship between irritable bowel syndrome and psychiatric disorders: from molecular changes to clinical manifestations , 2014, Journal of molecular psychiatry.
[12] R. Knight,et al. Finding the missing links among metabolites, microbes, and the host. , 2014, Immunity.
[13] Weixu Chen,et al. Implication of miRNAs for inflammatory bowel disease treatment: Systematic review. , 2014, World journal of gastrointestinal pathophysiology.
[14] A. Kostic,et al. The microbiome in inflammatory bowel disease: current status and the future ahead. , 2014, Gastroenterology.
[15] F. Shanahan,et al. Manipulation of the microbiota for treatment of IBS and IBD-challenges and controversies. , 2014, Gastroenterology.
[16] B. Dallapiccola,et al. The human gut microbiota: a dynamic interplay with the host from birth to senescence settled during childhood , 2014, Pediatric Research.
[17] Gerhard G. Thallinger,et al. A Physicians' Wish List for the Clinical Application of Intestinal Metagenomics , 2014, PLoS medicine.
[18] R. Sartor,et al. The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications , 2014, Journal of Gastroenterology.
[19] S. McClean,et al. Reduced E‐cadherin expression is associated with abdominal pain and symptom duration in a study of alternating and diarrhea predominant IBS , 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[20] Xiuping Liu,et al. Downregulation of microRNA‐107 in intestinal CD11c+ myeloid cells in response to microbiota and proinflammatory cytokines increases IL‐23p19 expression , 2014, European journal of immunology.
[21] N. Câmara,et al. Intestinal barrier: A gentlemen's agreement between microbiota and immunity. , 2014, World journal of gastrointestinal pathophysiology.
[22] M. Camilleri,et al. On the fiftieth anniversary Postinfectious irritable bowel syndrome: mechanisms related to pathogens , 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[23] L. Pieroni,et al. A metaproteomic pipeline to identify newborn mouse gut phylotypes. , 2014, Journal of proteomics.
[24] David P. Kreil,et al. Bacterial protein signals are associated with Crohn’s disease , 2014, Gut.
[25] A. Vaiopoulou,et al. Molecular basis of the irritable bowel syndrome. , 2014, World journal of gastroenterology.
[26] L. Henry,et al. Systematic review with meta‐analysis: non‐alcoholic steatohepatitis ‐ a case for personalised treatment based on pathogenic targets , 2014, Alimentary pharmacology & therapeutics.
[27] T. Brusko,et al. Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetes. , 2013, Immunotherapy.
[28] K. Verbeke,et al. Metabolomics as a diagnostic tool in gastroenterology. , 2013, World journal of gastrointestinal pharmacology and therapeutics.
[29] P. Scanlan,et al. Blastocystis: getting to grips with our guileful guest. , 2013, Trends in parasitology.
[30] C. Buffie,et al. Microbiota-mediated colonization resistance against intestinal pathogens , 2013, Nature Reviews Immunology.
[31] A. Dzutsev,et al. Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis. , 2013, Cell host & microbe.
[32] R. Burcelin,et al. Metagenome and metabolism: the tissue microbiota hypothesis , 2013, Diabetes, obesity & metabolism.
[33] J. Turner,et al. Intestinal permeability defects: is it time to treat? , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[34] P. Bork,et al. Richness of human gut microbiome correlates with metabolic markers , 2013, Nature.
[35] Mathieu Almeida,et al. Dietary intervention impact on gut microbial gene richness , 2013, Nature.
[36] P. Dorrestein,et al. Interspecies Interactions Stimulate Diversification of the Streptomyces coelicolor Secreted Metabolome , 2013, mBio.
[37] R. P. Ross,et al. Intestinal microbiota, diet and health , 2013, British Journal of Nutrition.
[38] E. Nimmo,et al. Beyond Gene Discovery in Inflammatory Bowel Disease: The Emerging Role of Epigenetics , 2013, Gastroenterology.
[39] C. Huttenhower,et al. Functional profiling of the gut microbiome in disease-associated inflammation , 2013, Genome Medicine.
[40] E. Seki,et al. Toll‐like receptors in alcoholic liver disease, non‐alcoholic steatohepatitis and carcinogenesis , 2013, Journal of gastroenterology and hepatology.
[41] Gaurav Agrawal,et al. Fecal Microbiota Transplantation: Indications, Methods, Evidence, and Future Directions , 2013, Current Gastroenterology Reports.
[42] R. Leong,et al. Proteomics and metabolomics in inflammatory bowel disease , 2013, Journal of gastroenterology and hepatology.
[43] Gabriel Núñez,et al. Control of pathogens and pathobionts by the gut microbiota , 2013, Nature Immunology.
[44] H. Sokol,et al. Faecalibacterium prausnitzii and human intestinal health. , 2013, Current opinion in microbiology.
[45] E. Lyon,et al. Probiotics, Prebiotics and Immunomodulation of Gut Mucosal Defences: Homeostasis and Immunopathology , 2013, Nutrients.
[46] A. Petersen,et al. Active ulcerative colitis associated with low prevalence of Blastocystis and Dientamoeba fragilis infection , 2013, Scandinavian journal of gastroenterology.
[47] N. Barnich,et al. Western diet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation , 2013, Gut.
[48] J. Bertrand-Michel,et al. Lipidomic and Spatio-Temporal Imaging of Fat by Mass Spectrometry in Mice Duodenum during Lipid Digestion , 2013, PloS one.
[49] G. Gloor,et al. Microbial ecosystems therapeutics: a new paradigm in medicine? , 2013, Beneficial microbes.
[50] C. R. Stensvold,et al. Waiting for the human intestinal Eukaryotome , 2013, The ISME Journal.
[51] A. Knoll,et al. Animals in a bacterial world, a new imperative for the life sciences , 2013, Proceedings of the National Academy of Sciences.
[52] Jie-shou Li,et al. Nonthyroidal Illness Syndrome: Is It Far Away From Crohn’s Disease? , 2013, Journal of clinical gastroenterology.
[53] Takuya Suzuki. Regulation of intestinal epithelial permeability by tight junctions , 2013, Cellular and Molecular Life Sciences.
[54] Brian C. Thomas,et al. Time series community genomics analysis reveals rapid shifts in bacterial species, strains, and phage during infant gut colonization , 2013, Genome research.
[55] Bernadette A. Thomas,et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.
[56] J. Nicholson,et al. Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. , 2012, Cell metabolism.
[57] J. Popp,et al. Sample size planning for classification models. , 2012, Analytica chimica acta.
[58] D. Elliott,et al. Where are we on worms? , 2012, Current opinion in gastroenterology.
[59] David C. Wilson,et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.
[60] Belgin Dogan,et al. Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota , 2012, Science.
[61] Francisco Guarner,et al. The gut microbiota in IBD , 2012, Nature Reviews Gastroenterology &Hepatology.
[62] N. Socci,et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[63] Enrico Capobianco,et al. Ten Challenges for Systems Medicine , 2012, Front. Gene..
[64] D. Raoult,et al. Human Gut Microbiota: Repertoire and Variations , 2012, Front. Cell. Inf. Microbio..
[65] R. Knight,et al. Diversity, stability and resilience of the human gut microbiota , 2012, Nature.
[66] T. Dinan,et al. Mind-altering Microorganisms: the Impact of the Gut Microbiota on Brain and Behaviour , 2022 .
[67] Nuno Bandeira,et al. Interkingdom metabolic transformations captured by microbial imaging mass spectrometry , 2012, Proceedings of the National Academy of Sciences.
[68] W. D. de Vos,et al. Early-life gut microbiota under physiological and pathological conditions: the central role of combined meta-omics-based approaches. , 2012, Journal of proteomics.
[69] Ruedi Aebersold,et al. Reproducible Quantification of Cancer-Associated Proteins in Body Fluids Using Targeted Proteomics , 2012, Science Translational Medicine.
[70] J. Söderholm,et al. Barrier dysfunction and bacterial uptake in the follicle‐associated epithelium of ileal Crohn's disease , 2012, Annals of the New York Academy of Sciences.
[71] E. Zoetendal,et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report , 2012, Gut.
[72] M. Balter. Taking Stock of the Human Microbiome and Disease , 2012, Science.
[73] F. Azpiroz,et al. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier , 2012, Gut.
[74] Katherine H. Huang,et al. Structure, Function and Diversity of the Healthy Human Microbiome , 2012, Nature.
[75] R. Alfenas,et al. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia , 2012, British Journal of Nutrition.
[76] J. Clemente,et al. Human gut microbiome viewed across age and geography , 2012, Nature.
[77] R. Vance,et al. Lethal inflammasome activation by a multi-drug resistant pathobiont upon antibiotic disruption of the microbiota , 2012, Nature Medicine.
[78] David R Goodlett,et al. Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study. , 2012, Journal of proteome research.
[79] Y. Ni,et al. Host-microbial interactions and regulation of intestinal epithelial barrier function: From physiology to pathology. , 2012, World journal of gastrointestinal pathophysiology.
[80] Qing Zeng-Treitler,et al. Predicting sample size required for classification performance , 2012, BMC Medical Informatics and Decision Making.
[81] G. Rook,et al. Hygiene Hypothesis and Autoimmune Diseases , 2012, Clinical Reviews in Allergy & Immunology.
[82] H. Kiyono,et al. Epithelial barrier: an interface for the cross‐communication between gut flora and immune system , 2012, Immunological reviews.
[83] J. Pekow,et al. MicroRNAs in inflammatory bowel disease , 2012, Inflammatory bowel diseases.
[84] M. Schmidt,et al. Differential Targeting of the E-Cadherin/β-Catenin Complex by Gram-Positive Probiotic Lactobacilli Improves Epithelial Barrier Function , 2011, Applied and Environmental Microbiology.
[85] Michael A Fischbach,et al. Eating for two: how metabolism establishes interspecies interactions in the gut. , 2011, Cell host & microbe.
[86] John F. Cryan,et al. Brain–Gut–Microbe Communication in Health and Disease , 2011, Front. Physio..
[87] F. Bushman,et al. Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes , 2011, Science.
[88] J. Walter,et al. The human gut microbiome: ecology and recent evolutionary changes. , 2011, Annual review of microbiology.
[89] Ateequr Rehman,et al. Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. , 2011, Gastroenterology.
[90] J. Gordon,et al. Human nutrition, the gut microbiome and the immune system , 2011, Nature.
[91] R. Knight,et al. Microbial Eukaryotes in the Human Microbiome: Ecology, Evolution, and Future Directions , 2011, Front. Microbio..
[92] P. Bork,et al. Enterotypes of the human gut microbiome , 2011, Nature.
[93] G. Dalmasso,et al. Microbiota Modulate Host Gene Expression via MicroRNAs , 2011, PloS one.
[94] M. Levings,et al. Environmental influences on T regulatory cells in inflammatory bowel disease. , 2011, Seminars in immunology.
[95] A. Darzi,et al. Gut microbiome-host interactions in health and disease , 2011, Genome Medicine.
[96] J. Parkhill,et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota , 2011, The ISME Journal.
[97] K. Honda,et al. Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species , 2011, Science.
[98] Julian Parkhill,et al. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease , 2011, BMC Microbiology.
[99] Tariq Ahmad,et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci , 2010, Nature Genetics.
[100] L. Putignani,et al. Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. , 2010, Endocrine reviews.
[101] J. Doré,et al. Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray , 2010, Inflammatory bowel diseases.
[102] A. Dignass,et al. Diagnosis and management of iron deficiency anemia in patients with IBD , 2010, Nature Reviews Gastroenterology &Hepatology.
[103] J. Doré,et al. Functional Metagenomics: A High Throughput Screening Method to Decipher Microbiota-Driven NF-κB Modulation in the Human Gut , 2010, PloS one.
[104] M. Abdollahi,et al. A review of the efficacy of traditional Iranian medicine for inflammatory bowel disease. , 2010, World journal of gastroenterology.
[105] Yu Guo,et al. Sample size and statistical power considerations in high-dimensionality data settings: a comparative study of classification algorithms , 2010, BMC Bioinformatics.
[106] J. Roth,et al. Gut inflammation provides a respiratory electron acceptor for Salmonella , 2010, Nature.
[107] S. Massart,et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa , 2010, Proceedings of the National Academy of Sciences.
[108] A. Ivanov,et al. Cytoskeletal regulation of epithelial barrier function during inflammation. , 2010, The American journal of pathology.
[109] J. Neu,et al. The infant intestinal microbiome: friend or foe? , 2010, Early human development.
[110] M. Heikenwalder,et al. Reversible Microbial Colonization of Germ-Free Mice Reveals the Dynamics of IgA Immune Responses , 2010, Science.
[111] A. Weiss,et al. EspM inhibits pedestal formation by enterohaemorrhagic Escherichia coli and enteropathogenic E. coli and disrupts the architecture of a polarized epithelial monolayer , 2010, Cellular microbiology.
[112] P. Bork,et al. A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.
[113] R. Knight,et al. Bacterial Community Variation in Human Body Habitats Across Space and Time , 2009, Science.
[114] S. Fukudo,et al. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[115] Jerrold R. Turner,et al. Intestinal mucosal barrier function in health and disease , 2009, Nature Reviews Immunology.
[116] Dan R. Littman,et al. Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria , 2009, Cell.
[117] R. Xavier,et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 , 2009, Nature.
[118] Pieter C. Dorrestein,et al. Translating metabolic exchange with imaging mass spectrometry , 2009, Nature chemical biology.
[119] L. Mølbak,et al. Better living through microbial action: the benefits of the mammalian gastrointestinal microbiota on the host. , 2009, Environmental microbiology.
[120] P. Whorwell,et al. Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial , 2009, BMJ : British Medical Journal.
[121] Michael D. George,et al. Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. , 2009, Cell host & microbe.
[122] S. Mazmanian,et al. The gut microbiota shapes intestinal immune responses during health and disease , 2009, Nature Reviews Immunology.
[123] P. Rutgeerts,et al. Pouchitis, Similar to Active Ulcerative Colitis, Is Associated with Impaired Butyrate Oxidation by Intestinal Mucosa , 2009, Inflammatory bowel diseases.
[124] I. Adlerberth,et al. Establishment of the gut microbiota in Western infants , 2009, Acta paediatrica.
[125] Gérard Eberl,et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis , 2008, Nature.
[126] M. Spehlmann,et al. Epidemiology of inflammatory bowel disease in a German twin cohort: Results of a nationwide study , 2008, Inflammatory bowel diseases.
[127] Asher Mullard. Microbiology: The inside story , 2008, Nature.
[128] S. Ghosh,et al. Shared Principles in NF-κB Signaling , 2008, Cell.
[129] P. Ducrotte. Syndrome de l'intestin irritable : options thérapeutiques actuelles , 2007 .
[130] D. Jonkers,et al. Review article: the role of butyrate on colonic function , 2007, Alimentary pharmacology & therapeutics.
[131] L. Šver,et al. Immune development in jejunal mucosa after colonization with selected commensal gut bacteria: a study in germ-free pigs. , 2007, Veterinary immunology and immunopathology.
[132] R. Coda,et al. Synthesis of γ-Aminobutyric Acid by Lactic Acid Bacteria Isolated from a Variety of Italian Cheeses , 2007, Applied and Environmental Microbiology.
[133] C. Knauf,et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia , 2007, Diabetologia.
[134] F. Barreau,et al. New Insights in the Etiology and Pathophysiology of Irritable Bowel Syndrome: Contribution of Neonatal Stress Models , 2007, Pediatric Research.
[135] N. Pace,et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases , 2007, Proceedings of the National Academy of Sciences.
[136] B. Finlay,et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. , 2007, Cell host & microbe.
[137] J. Corander,et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. , 2007, Gastroenterology.
[138] W. Sandborn,et al. Inflammatory bowel disease: clinical aspects and established and evolving therapies , 2007, The Lancet.
[139] A. Gruber,et al. Epithelial-cell-intrinsic IKK-β expression regulates intestinal immune homeostasis , 2007, Nature.
[140] M. Neurath,et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation , 2007, Nature.
[141] E. Quigley. Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management , 2007, Journal of digestive diseases.
[142] N. Barnich,et al. Adherent-invasive Escherichia coli and Crohn's disease , 2007, Current opinion in gastroenterology.
[143] E. Björnsson,et al. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome , 2006, Gut.
[144] R. Balshaw,et al. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study. , 2006, Clinical therapeutics.
[145] A. Nusrat,et al. Inflammatory Bowel Disease and the Apical Junctional Complex , 2006, Annals of the New York Academy of Sciences.
[146] R. D. de Souza,et al. Colonic Health: Fermentation and Short Chain Fatty Acids , 2006, Journal of clinical gastroenterology.
[147] D. Drossman,et al. A Survey on Patient Educational Needs in Irritable Bowel Syndrome and Attitudes Toward Participation in Clinical Research , 2006, Journal of clinical gastroenterology.
[148] C. Manichanh,et al. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach , 2005, Gut.
[149] R. Malekzadeh,et al. The effect of fluoxetine in patients with pain and constipation‐predominant irritable bowel syndrome: a double‐blind randomized‐controlled study , 2005, Alimentary pharmacology & therapeutics.
[150] C. Bernstein,et al. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. , 2005, Gastroenterology.
[151] J. Eiserich,et al. Differential regulation of dual NADPH oxidases/peroxidases, Duox1 and Duox2, by Th1 and Th2 cytokines in respiratory tract epithelium , 2005, FEBS letters.
[152] E. Purdom,et al. Diversity of the Human Intestinal Microbial Flora , 2005, Science.
[153] J. J. Windsor,et al. Irritable bowel syndrome: the need to exclude Dientamoeba fragilis. , 2005, The American journal of tropical medicine and hygiene.
[154] M. Blaut,et al. Modulation of gut mucosal biofilms , 2005, British Journal of Nutrition.
[155] F. Bäckhed,et al. Host-Bacterial Mutualism in the Human Intestine , 2005, Science.
[156] T. Ohkusa,et al. Antibacterial and antimycobacterial treatment for inflammatory bowel disease , 2005, Journal of gastroenterology and hepatology.
[157] Ting Wang,et al. The gut microbiota as an environmental factor that regulates fat storage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[158] Ruslan Medzhitov,et al. Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.
[159] Yu-jing Fan,et al. Intestinal microecology and quality of life in irritable bowel syndrome patients. , 2004, World journal of gastroenterology.
[160] B. Cukrowska,et al. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. , 2004, Immunology letters.
[161] R Balfour Sartor,et al. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. , 2004, Gastroenterology.
[162] G. Matarese,et al. The weight of leptin in immunity , 2004, Nature Reviews Immunology.
[163] M. Beg,et al. Irritable bowel syndrome: in search of an etiology: role of Blastocystis hominis. , 2004, The American journal of tropical medicine and hygiene.
[164] N. Talley. Scope of the problem of functional digestive disorders. , 2003, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.
[165] A. Keshavarzian,et al. Intestinal barrier: An interface between health and disease , 2003, Journal of gastroenterology and hepatology.
[166] S. Savkovic,et al. Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation , 2003, Gut.
[167] Jeffrey I. Gordon,et al. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[168] H. Lührs,et al. Butyrate Inhibits NF-κB Activation in Lamina Propria Macrophages of Patients with Ulcerative Colitis , 2002, Scandinavian journal of gastroenterology.
[169] G. Scalise,et al. Irritable Bowel Syndrome in Patients with Blastocystis hominis Infection , 1999, European Journal of Clinical Microbiology and Infectious Diseases.
[170] Stephen R. Bloom,et al. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression , 1998, Nature.
[171] Chyung-Ru Wang,et al. Helper T cell differentiation is controlled by the cell cycle. , 1998, Immunity.
[172] M. Roberfroid,et al. Functional food science and gastrointestinal physiology and function , 1998, British Journal of Nutrition.
[173] J. Hampe,et al. Activation of nuclear factor κB in inflammatory bowel disease , 1998, Gut.
[174] C. Fiorentini,et al. Escherichia coli Cytotoxic Necrotizing Factor 1 (CNF1), a Toxin That Activates the Rho GTPase* , 1997, The Journal of Biological Chemistry.
[175] J. R. Smith,et al. Role of intestinal epithelial cells in the host secretory response to infection by invasive bacteria. Bacterial entry induces epithelial prostaglandin h synthase-2 expression and prostaglandin E2 and F2alpha production. , 1997, The Journal of clinical investigation.
[176] J. Belaiche,et al. Clinical characteristics of Crohn's disease in 72 families. , 1996, Gastroenterology.
[177] M. O’connor,et al. Induction and activity of nitric oxide synthase in cultured human intestinal epithelial monolayers. , 1996, The American journal of physiology.
[178] J. Spencer,et al. E-cadherin expression in intestinal epithelium. , 1995, Journal of clinical pathology.
[179] P. Hellström,et al. Greatly increased luminal nitric oxide in ulcerative colitis , 1994, The Lancet.
[180] S. Moncada,et al. Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.
[181] M. Tvede,et al. Rectal bacteriotherapy for recurrent Clostridium difficile-associated diarrhoea: results from a case series of 55 patients in Denmark 2000-2012. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[182] L. Öhman,et al. Crosstalk at the mucosal border: importance of the gut microenvironment in IBS , 2015, Nature Reviews Gastroenterology &Hepatology.
[183] M. Geuking,et al. Pathological bacterial translocation in liver cirrhosis. , 2014, Journal of hepatology.
[184] Peter Holzer,et al. Neuropeptides and the microbiota-gut-brain axis. , 2014, Advances in experimental medicine and biology.
[185] P. Gibson,et al. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. , 2014, Gastroenterology.
[186] Kp Suresh,et al. Sample size estimation and power analysis for clinical research studies , 2012, Journal of human reproductive sciences.
[187] E. Szigethy,et al. Inflammatory bowel disease. , 2011, Pediatric clinics of North America.
[188] Evie McCrum-Gardner,et al. Sample size and power calculations made simple , 2010 .
[189] D. Doman,et al. Probiotic therapy for irritable bowel syndrome. , 2010, Gastroenterology & hepatology.
[190] E. Stein,et al. GERD: GERD and insomnia—first degree relatives or distant cousins? , 2010, Nature Reviews Gastroenterology &Hepatology.
[191] B. Staels,et al. Role of bile acids and bile acid receptors in metabolic regulation. , 2009, Physiological reviews.
[192] Luying Peng,et al. Effects of Butyrate on Intestinal Barrier Function in a Caco-2 Cell Monolayer Model of Intestinal Barrier , 2007, Pediatric Research.
[193] D. Stark,et al. Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis. , 2007, International journal for parasitology.
[194] P. Ducrotte. [Irritable bowel syndrome: current treatment options]. , 2007, Presse medicale.
[195] Stephen P Myers,et al. The causes of intestinal dysbiosis: a review. , 2004, Alternative medicine review : a journal of clinical therapeutic.
[196] Sayan Mukherjee,et al. Estimating Dataset Size Requirements for Classifying DNA Microarray Data , 2003, J. Comput. Biol..
[197] Alan D. Lopez,et al. The Global Burden of Disease Study , 2003 .
[198] K. E. Shroff,et al. Development and Maintenance of the Gut-Associated Lymphoid Tissue (Galt): the Roles of Enteric Bacteria and Viruses , 1998, Developmental immunology.
[199] L. Collins,et al. Seven ways to increase power without increasing N. , 1994, NIDA research monograph.